A A Bartels-Velthuis1, J T W Wigman1, J A Jenner2, R Bruggeman1, J van Os3,4. 1. University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Groningen, the Netherlands. 2. Jenner Consult, Haren, the Netherlands. 3. Maastricht University Medical Centre, Department of Psychiatry and Psychology, Maastricht, the Netherlands. 4. King's College London, King's Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, UK.
Abstract
OBJECTIVE: Childhood auditory vocal hallucinations (AVH) are mostly transient but may predict clinical outcomes. Little is known about their course over time and associations with risk factors, and how this may inform early intervention. Our objective was to assess the 11-year course of AVH, associated psychopathology and risk factors. METHOD: A 5-year (T1) and 11-year (T2) follow-up of a baseline case-control sample (n = 694, of whom 347 with AVH). At T2, online assessment of AVH, other psychotic experiences, psychopathology, trauma and cannabis use was completed by 293 adolescents aged 18-19 years. RESULTS: The AVH 6-year (T1-T2) persistence rate was 18.2%, and the AVH 11-year (T0-T2) persistence rate was 6.2%. AVH at T2 were associated with higher levels of T2 other psychotic experiences, T2 psychopathology and T2 traumatic events, but not with T2 stress or T2 cannabis use. Persistence of AVH (i.e. AVH reported two or three times from T0) was associated with T2 traumatic events and higher risk for post-traumatic stress disorder. CONCLUSION: Auditory vocal hallucinations in early childhood are mostly transitory. AVH in adolescence, especially when persistent, are associated with affective symptoms and environmental risk, particularly traumatic events.
OBJECTIVE: Childhood auditory vocal hallucinations (AVH) are mostly transient but may predict clinical outcomes. Little is known about their course over time and associations with risk factors, and how this may inform early intervention. Our objective was to assess the 11-year course of AVH, associated psychopathology and risk factors. METHOD: A 5-year (T1) and 11-year (T2) follow-up of a baseline case-control sample (n = 694, of whom 347 with AVH). At T2, online assessment of AVH, other psychotic experiences, psychopathology, trauma and cannabis use was completed by 293 adolescents aged 18-19 years. RESULTS: The AVH 6-year (T1-T2) persistence rate was 18.2%, and the AVH 11-year (T0-T2) persistence rate was 6.2%. AVH at T2 were associated with higher levels of T2 other psychotic experiences, T2 psychopathology and T2 traumatic events, but not with T2 stress or T2 cannabis use. Persistence of AVH (i.e. AVH reported two or three times from T0) was associated with T2 traumatic events and higher risk for post-traumatic stress disorder. CONCLUSION:Auditory vocal hallucinations in early childhood are mostly transitory. AVH in adolescence, especially when persistent, are associated with affective symptoms and environmental risk, particularly traumatic events.
Authors: Marialuisa Cavelti; Janko M Kaeser; Stefan Lerch; Stephanie Bauer; Markus Moessner; Thomas Berger; Mark Hayward; Michael Kaess Journal: Trials Date: 2022-10-23 Impact factor: 2.728
Authors: Johanna T W Wigman; Stijn de Vos; Marieke Wichers; Jim van Os; Agna A Bartels-Velthuis Journal: Schizophr Bull Date: 2016-07-06 Impact factor: 9.306
Authors: Alexandros Rammos; Sarah A Sullivan; Daphne Kounali; Hannah J Jones; Gemma Hammerton; Lindsey A Hines; Glyn Lewis; Peter B Jones; Mary Cannon; Andrew Thompson; Dieter Wolke; Jon Heron; Stanley Zammit Journal: Br J Psychiatry Date: 2021-10-06 Impact factor: 10.671
Authors: Marco Armando; Maude Schneider; Maria Pontillo; Stefano Vicari; Martin Debbané; Frauke Schultze-Lutter; Stephan Eliez Journal: PLoS One Date: 2017-04-13 Impact factor: 3.240
Authors: Vera Brink; Catheleine van Driel; Saliha El Bouhaddani; Klaas J Wardenaar; Lieke van Domburgh; Barbara Schaefer; Marije van Beilen; Agna A Bartels-Velthuis; Wim Veling Journal: Eur Child Adolesc Psychiatry Date: 2019-08-27 Impact factor: 4.785
Authors: Susanna Roberts; Matthew Suderman; Stanley Zammit; Sarah H Watkins; Eilis Hannon; Jonathan Mill; Caroline Relton; Louise Arseneault; Chloe C Y Wong; Helen L Fisher Journal: Transl Psychiatry Date: 2019-02-04 Impact factor: 6.222
Authors: Kim Maijer; Mark Hayward; Charles Fernyhough; Monica E Calkins; Martin Debbané; Renaud Jardri; Ian Kelleher; Andrea Raballo; Aikaterini Rammou; James G Scott; Ann K Shinn; Laura A Steenhuis; Daniel H Wolf; Agna A Bartels-Velthuis Journal: Schizophr Bull Date: 2019-02-01 Impact factor: 9.306
Authors: Laura A Steenhuis; Gerdina H M Pijnenborg; Jim van Os; André Aleman; Maaike H Nauta; Agna A Bartels-Velthuis Journal: PLoS One Date: 2019-02-28 Impact factor: 3.240